These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 3103947)

  • 1. Structure-activity studies of the indole alkaloid tumor promoter teleocidins.
    Irie K; Hagiwara N; Tokuda H; Koshimizu K
    Carcinogenesis; 1987 Apr; 8(4):547-52. PubMed ID: 3103947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-activity studies of aplysiatoxin-type tumor promoters.
    Moore RE
    Princess Takamatsu Symp; 1983; 14():49-57. PubMed ID: 6243065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Similar, potent tumor-promoting activity of all isomers of teleocidins A and B in a two-stage carcinogenesis experiment on the skin of CD-1 mice.
    Fujiki H; Suganuma M; Ninomiya M; Yoshizawa S; Yamashita K; Takayama S; Hitotsuyanagi Y; Sakai S; Shudo K; Sugimura T
    Cancer Res; 1988 Aug; 48(15):4211-4. PubMed ID: 3134123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative effects of aplysiatoxin, debromoaplysiatoxin, and teleocidin on receptor binding and phospholipid metabolism.
    Horowitz AD; Fujiki H; Weinstein IB; Jeffrey A; Okin E; Moore RE; Sugimura T
    Cancer Res; 1983 Apr; 43(4):1529-35. PubMed ID: 6299522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative structure-activity studies on indole alkaloid tumor promoter indolactam congeners.
    Irie K; Okuno S; Kajiyama S; Koshimizu K; Nishino H; Iwashima A
    Carcinogenesis; 1991 Oct; 12(10):1883-6. PubMed ID: 1934269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biological activities and cellular uptake studies of fluorescent derivatives of indole alkaloid tumor promoter teleocidin.
    Irie K; Okuno S; Koshimizu K; Tokuda H; Nishino H; Iwashima A
    Int J Cancer; 1989 Mar; 43(3):513-9. PubMed ID: 2538401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-activity relationship in the induction of Epstein-Barr virus by teleocidin derivatives.
    Irie K; Tokuda H; Hagiwara N; Koshimizu K; Hayashi H; Murao S; Ito Y
    Int J Cancer; 1985 Oct; 36(4):485-8. PubMed ID: 2995261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The metabolism of indole alkaloid tumor promoter, (-)-indolactam V, which has the fundamental structure of teleocidins, by rat liver microsomes.
    Hagiwara N; Irie K; Tokuda H; Koshimizu K
    Carcinogenesis; 1987 Jul; 8(7):963-5. PubMed ID: 3109758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthetic analogues (indolactams) of (-)-indolactam-V are new congeners of the teleocidin class of tumor promoters.
    Hirota M; Suganuma M; Yoshizawa S; Horiuchi T; Nakayasu M; Hasegawa M; Endo Y; Shudo K; Fujiki H
    Jpn J Cancer Res; 1987 Jun; 78(6):577-82. PubMed ID: 3112073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pendolmycin, a new tumor promoter of the teleocidin A class on skin of CD-1 mice.
    Nishiwaki S; Fujiki H; Yoshizawa S; Suganuma M; Furuya-Suguri H; Okabe S; Nakayasu M; Okabe K; Muratake H; Natsume M
    Jpn J Cancer Res; 1991 Jul; 82(7):779-83. PubMed ID: 1908844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of phorbol ester receptors in mouse skin by application of quercetin.
    Horiuchi T; Fujiki H; Hakii H; Suganuma M; Yamashita K; Sugimura T
    Jpn J Cancer Res; 1986 Jun; 77(6):526-31. PubMed ID: 3089985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Irritant diterpene ester promoters of mouse skin: contributions to etiologies of environmental cancer and to biochemical mechanisms of carcinogenesis.
    Hecker E; Adolf W; Hergenhahn M; Schmidt R; Sorg B
    Princess Takamatsu Symp; 1983; 14():3-36. PubMed ID: 6097581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-activity studies on synthetic analogues (indolactams) of the tumor promoter teleocidin.
    Fujiki H; Suganuma M; Nakayasu M; Tahira T; Endo Y; Shudo K; Sugimura T
    Gan; 1984 Oct; 75(10):866-70. PubMed ID: 6595181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on olivoretins indicate a requirement for a free hydroxyl group for teleocidin B activity.
    Horiuchi T; Fujiki H; Suganuma M; Hakii H; Nakayasu M; Hitotsuyanagi Y; Aimi N; Sakai S; Endo Y; Shudo K
    Gan; 1984 Oct; 75(10):837-40. PubMed ID: 6439591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific binding of phorbol ester tumor promoters to mouse tissues and cultured cells.
    Blumberg PM; Delclos KB; Dunphy WG; Jaken S
    Carcinog Compr Surv; 1982; 7():519-35. PubMed ID: 7039833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific lipid components in membrane receptors of 12-O-tetradecanoylphorbol-13-acetate as revealed by direct photoaffinity labelling.
    Hergenhahn M; Hecker E
    IARC Sci Publ; 1984; (56):165-75. PubMed ID: 6536595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimation of tumor promoting activity and structure-function relationships of aplysiatoxins.
    Suganuma M; Fujiki H; Tahira T; Cheuk C; Moore RE; Sugimura T
    Carcinogenesis; 1984 Mar; 5(3):315-8. PubMed ID: 6323046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular mechanisms of tumor promotion and multistage carcinogenesis.
    Weinstein IB; Arcoleo J; Backer J; Jeffrey A; Hsiao WL; Gattoni-Celli S; Kirschmeier P; Okin E
    Princess Takamatsu Symp; 1983; 14():59-74. PubMed ID: 6097583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Promoter-induced cellular responses closely correlated with the enhancement of cell transformation.
    Kakunaga T; Hirakawa T; Shimomura K; Sugimura T
    Princess Takamatsu Symp; 1983; 14():303-13. PubMed ID: 6097582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clarification of the binding mode of teleocidin and benzolactams to the Cys2 domain of protein kinase Cdelta by synthesis of hydrophobically modified, teleocidin-mimicking benzolactams and computational docking simulation.
    Endo Y; Takehana S; Ohno M; Driedger PE; Stabel S; Mizutani MY; Tomioka N; Itai A; Shudo K
    J Med Chem; 1998 Apr; 41(9):1476-96. PubMed ID: 9554881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.